申请人:——
公开号:US20040147572A1
公开(公告)日:2004-07-29
The present invention relates to compounds of formula (I)
1
wherein R
1
, R
2
, R
3
, R
4
, R
5
, R
6
and R
7
are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with the modulation of CB1 receptors.
本发明涉及公式(I)1中的化合物,其中R1、R2、R3、R4、R5、R6和R7如描述和索赔中定义,并其药用盐。这些化合物可用于治疗和/或预防与CB1受体调节相关的疾病。